Legal News

EU regulatory plan targets big pharma competition, mergers

Published on: 27 November 2020
Published by: Law360
  • EU regulatory plan targets big pharma competition, mergers

Article summary

Law360: The European Commission on 25 November 2020 adopted a plan to develop a regulatory framework by 2022 to increase access to cheap generic drugs by cracking down on anti-competitive behaviours by pharmaceutical companies across the EU. or take a trial to read the full analysis.

Popular documents